Physician profile
Bart Robbins
NPI 1093703902
$1,415.35
in general payments reported to CMS, 2019-2025
14 companies · $33.87 in 2025
The $33.87 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $202 · 2021: $333 · 2022: $165 · 2023: $272 · 2024: $241 · 2025: $33.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $260.19 | 2021-2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $235.89 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $213.42 | 2019-2024 | Dyanavel Xr |
| Corium, LLC | $187.70 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $115.72 | 2022-2024 | Bexsero, Pediarix, Rotarix |
| Neos Therapeutics, Lp | $115.27 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.85 | 2020-2021 | |
| Adlon Therapeutics L.P. | $49.05 | 2019-2021 | |
| Cranial Technologies, INC | $47.07 | 2021-2024 | Doc Band |
| Pfizer INC. | $35.87 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $33.87 | 2025 | Jornay Pm |
| Shire North American Group INC | $33.25 | 2019 | |
| Sanofi Pasteur INC. | $13.22 | 2019 | |
| Kaleo, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.